Severe intractable asthma.
Severe persistent asthma has been defined as being symptomatic every day with distur- bance of daily life. To judge asthma as severe and intractable, besides misdiagnosis, treatment step 4 has been properly done with good adherence, appropriate management of comorbidi- ties, avoidance of risk factors. Management for severe intractable asthma consists of thera- peutic step 4 with adjustment of the dose of sustained release theophylline by a step-wise manner with therapeutic dose monitoring, and selection of ICS or ICS/LABA considering individual state, and selecting intermittent administration of OCS and/or anti-IgE(omali- zumab) or anti-IL-5 (mepolizumab) antibodies after getting informed consent from a patient.